We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
(+14%)
Cap. Flow
+$639M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Okta
OKTA
|
+$37.2M |
| 2 |
Linde
LIN
|
+$31.4M |
| 3 |
Take-Two Interactive
TTWO
|
+$30M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$27.4M |
| 5 |
Walmart Inc
WMT
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aptiv
APTV
|
+$46.1M |
| 2 |
PayPal
PYPL
|
+$31.4M |
| 3 |
Apple
AAPL
|
+$31.3M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$28M |
| 5 |
Merck
MRK
|
+$27.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.34% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Healthcare | 13.89% |
| 4 | Industrials | 12.4% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VXRT
2626
DELISTED
Vaxart
VXRT
| $164K | ﹤0.01% |
21,891
-709
| -3% | -$4.95K |
|
|
PVLA
2627
Palvella Therapeutics
PVLA
$2.27B
| $163K | ﹤0.01% |
+533
| New | +$117K |
|
|
TCS
2628
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $161K | ﹤0.01% |
822
-1,080
| -57% | -$225K |
|
2629
Blue Owl Capital
OBDC
$5.74B
| $160K | ﹤0.01% |
11,185
-90,704
| -89% | -$1.3M |
|
|
NBEV
2630
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $160K | ﹤0.01% |
71,722
-26,992
| -27% | -$62.9K |
|
|
PEI
2631
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $158K | ﹤0.01% |
+4,217
| New | +$138K |
|
2632
Pampa Energía
PAM
$4.41B
| $156K | ﹤0.01% |
+10,286
| New | +$156K |
|
|
TIGR
2633
UP Fintech Holding
TIGR
$861M
| $156K | ﹤0.01% |
5,367
-57,033
| -91% | -$1.21M |
|
2634
NextDecade
NEXT
$1.78B
| $155K | ﹤0.01% |
37,607
-29,197
| -44% | -$82.3K |
|
|
AMRN
2635
Amarin Corp
AMRN
$303M
| $154K | ﹤0.01% |
1,761
-16,291
| -90% | -$1.6M |
|
2636
Fresenius Medical Care
FMS
$12.9B
| $154K | ﹤0.01% |
+3,714
| New | +$148K |
|
2637
Green Brick Partners
GRBK
$3.14B
| $154K | ﹤0.01% |
6,771
-6,829
| -50% | -$164K |
|
|
NPTN
2638
DELISTED
NEOPHOTONICS CORP
NPTN
| $154K | ﹤0.01% |
15,103
+3,680
| +32% | +$38.8K |
|
2639
Nordic American Tanker
NAT
$1.37B
| $153K | ﹤0.01% |
46,529
+46,378
| +30,714% | +$157K |
|
|
NNDM
2640
Nano Dimension
NNDM
$343M
| $153K | ﹤0.01% |
+18,614
| New | +$138K |
|
2641
SandRidge Energy
SD
$503M
| $153K | ﹤0.01% |
24,358
+9,576
| +65% | +$48.1K |
|
|
ALE
2642
DELISTED
Allete
ALE
| $147K | ﹤0.01% |
2,107
-26,639
| -93% | -$1.86M |
|
2643
MACOM Technology Solutions
MTSI
$23.7B
| $147K | ﹤0.01% |
2,298
-56,985
| -96% | -$3.31M |
|
2644
Melco Resorts & Entertainment
MLCO
$2.14B
| $146K | ﹤0.01% |
8,829
-81,155
| -90% | -$1.47M |
|
2645
Resources Connection
RGP
$145M
| $146K | ﹤0.01% |
10,176
-5,061
| -33% | -$73.1K |
|
|
TRML
2646
DELISTED
Tourmaline Bio
TRML
| $146K | ﹤0.01% |
+992
| New | +$152K |
|
|
VIOT
2647
Viomi Technology
VIOT
$49.2M
| $146K | ﹤0.01% |
17,139
-2,379
| -12% | -$19.4K |
|
2648
Zevra Therapeutics
ZVRA
$686M
| $146K | ﹤0.01% |
+11,403
| New | +$123K |
|
|
LOGC
2649
DELISTED
ContextLogic
LOGC
| $146K | ﹤0.01% |
370
-4,658
| -93% | -$1.65M |
|
|
ALR
2650
DELISTED
AlerisLife Inc
ALR
| $146K | ﹤0.01% |
+25,426
| New | +$145K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q2 2021 Portfolio in Review
As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.
- Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
- Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
- Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
- Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
- Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
- Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
- Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.
Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.